iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease

There are a number of guidelines on how to manage obesity, but inconsistencies in healthcare access, varying infrastructure, resource constraints and diverse local practices restrict their global applicability. This underscores the need for universal recommendations that address the unique challenges faced by patients and healthcare providers worldwide. Our Global Guidelines emphasize the incorporation of novel therapies, while integrating standards of care with the most up-to-date evidence to enable clinicians to optimize obesity management. Context-specific recommendations tailored to individual patient needs are highlighted, providing a thorough evaluation of the risks, benefits, and overall value of each therapy, aiming to establish a standard of care that improves patient outcomes and reduces the burden of hospitalization in this susceptible population. These Global Guidelines provide evidence-based recommendations that represent a group consensus considering the many other published guidelines that have reviewed many of the issues discussed here, but they also make new recommendations where new evidence has recently emerged, and – most importantly – also provide recommendations on several issues where resource limitations may put constraints on the care provided to patients living with obesity. Such “economic adjustment” recommendations aim to guide situations when “Resources are somewhat limited” or when “Resources are severely limited”. Hence, this document presents a comprehensive update to obesity management guidelines, thereby aiming to provide a unified strategy for the pharmacological, non-pharmacological, and invasive management of this significant global health challenge that is applicable to the needs of healthcare around the globe.

Institutions

Publication Details

Journal
Global Cardiology
Published
2025-09-30
DOI
https://doi.org/10.4081/cardio.2025.86
Citations
2
Primary Topic
Genetics, Bioinformatics, and Biomedical Research
Type
article
Field-Weighted Citation Impact
1.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease

2 citations
Global Cardiology
Genetics, Bioinformatics, and Biomedical Research
1.61
article

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease

article en
2 citations

Abstract

There are a number of guidelines on how to manage obesity, but inconsistencies in healthcare access, varying infrastructure, resource constraints and diverse local practices restrict their global applicability. This underscores the need for universal recommendations that address the unique challenges faced by patients and healthcare providers worldwide. Our Global Guidelines emphasize the incorporation of novel therapies, while integrating standards of care with the most up-to-date evidence to enable clinicians to optimize obesity management. Context-specific recommendations tailored to individual patient needs are highlighted, providing a thorough evaluation of the risks, benefits, and overall value of each therapy, aiming to establish a standard of care that improves patient outcomes and reduces the burden of hospitalization in this susceptible population. These Global Guidelines provide evidence-based recommendations that represent a group consensus considering the many other published guidelines that have reviewed many of the issues discussed here, but they also make new recommendations where new evidence has recently emerged, and – most importantly – also provide recommendations on several issues where resource limitations may put constraints on the care provided to patients living with obesity. Such “economic adjustment” recommendations aim to guide situations when “Resources are somewhat limited” or when “Resources are severely limited”. Hence, this document presents a comprehensive update to obesity management guidelines, thereby aiming to provide a unified strategy for the pharmacological, non-pharmacological, and invasive management of this significant global health challenge that is applicable to the needs of healthcare around the globe.

Global CardiologyVol. 3(3)
University College Dublin (IE), Pennington Biomedical Research Center (US), Ain Shams University (EG), University of North Carolina at Chapel Hill (US), Australian National University (AU), Bond University (AU), Cedars-Sinai Medical Center (US), St. Michael's Hospital (CA), Cleveland Clinic (US), Apollo Hospitals (IN), Steno Diabetes Centers (DK), University of Lisbon (PT), Nanchang University (CN), Medical University of South Carolina (US), University of Leicester (GB), Vita-Salute San Raffaele University (IT), Volgograd State Medical University (RU), University of California, Los Angeles (US), University of Douala (CM), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), Medical College of Wisconsin (US), Slovak Academy of Sciences (SK), Instituto Cajal (ES), Royal Brisbane and Women's Hospital (AU), St. Boniface Hospital (CA), University College Hospital, Ibadan (NG), The Heart Research Institute (AU), Baylor University Medical Center (US), Max Super Speciality Hospital (IN), Academy of Nutrition and Dietetics (US), The Ohio State University Wexner Medical Center (US), San Raffaele University of Rome (IT), University of Mississippi Medical Center (US), Universidade do Estado do Rio de Janeiro (BR), Shilpa (India) (IN), Institute of Post Graduate Medical Education and Research (IN), Hospital Universitario Fundación Alcorcón (ES), Instituto Nacional de Cardiologia (BR), Second Affiliated Hospital of Nanchang University (CN), Centennial Medical Group (US), Heart Hospital Baylor Plano (US), Precision for Medicine (United States) (US), Peking University People's Hospital (CN), Mediclinic City Hospital (AE), German Centre for Cardiovascular Research (DE), St Michael's Hospital (GB), Diabetes Care & Hormone Clinic (IN), Unidad de Cirugía Cardiovascular de Guatemala (GT), Providence Center (US), Institut universitaire de cardiologie et de pneumologie de Québec (CA), Bombay Hospital (IN), Velocity Clinical Research (United States) (US), Centre Hospitalier Universitaire Ibn Rochd (MA), Cedars-Sinai Smidt Heart Institute (US), Woodlands Health Campus (SG), Teerthanker Mahaveer Medical College & Research Centre (IN), Beijing Tsinghua Chang Gung Hospital (CN), Woodlands Hospital (GB), Baylor Scott & White Health (US), Hospital Universitario Ramón y Cajal (ES), Fu Wai Hospital (CN), Toranomon Hospital (JP), University of Florence (IT), University of Glasgow (GB), University of Abuja (NG), Institute for Social Security and Services for State Workers (MX), Providence Health & Services (US), Tsinghua University (CN)
Industry, innovation and infrastructure
Openalex Percentile: Top 14%
Genetics, Bioinformatics, and Biomedical Research
1.61
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.